150 related articles for article (PubMed ID: 9613821)
1. New sialyltransferase inhibitors based on CMP-quinic acid: development of a new sialyltransferase assay.
Schaub C; Müller B; Schmidt RR
Glycoconj J; 1998 Apr; 15(4):345-54. PubMed ID: 9613821
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.
Whalen LJ; McEvoy KA; Halcomb RL
Bioorg Med Chem Lett; 2003 Jan; 13(2):301-4. PubMed ID: 12482445
[TBL] [Abstract][Full Text] [Related]
3. Studies on the inhibition of sialyl- and galactosyltransferases.
Kleineidam RG; Schmelter T; Schwarz RT; Schauer R
Glycoconj J; 1997 Jan; 14(1):57-66. PubMed ID: 9076514
[TBL] [Abstract][Full Text] [Related]
4. Design of fluorogenic substrates for continuous assay of sialyltransferase by resonance energy transfer.
Washiya K; Furuike T; Nakajima F; Lee YC; Nishimura SI
Anal Biochem; 2000 Jul; 283(1):39-48. PubMed ID: 10929806
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of an anomeric sulfur analogue of CMP-sialic acid.
Cohen SB; Halcomb RL
J Org Chem; 2000 Sep; 65(19):6145-52. PubMed ID: 10987952
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic synthesis of Kdn oligosaccharides by a bacterial alpha-(2-->6)-sialyltransferase.
Kajihara Y; Akai S; Nakagawa T; Sato R; Ebata T; Kodama H; Sato K
Carbohydr Res; 1999 Jan; 315(1-2):137-41. PubMed ID: 10385976
[TBL] [Abstract][Full Text] [Related]
7. Characterization of inhibitory activities and binding mode of synthetic 6'-modified methyl N-acetyl-beta-lactosaminide toward rat liver CMP-D-Neu5Ac: D-galactoside-(2-->6)-alpha-D-sialyltransferase.
Kajihara Y; Kodama H; Wakabayashi T; Sato K; Hashimoto H
Carbohydr Res; 1993 Sep; 247():179-93. PubMed ID: 8221719
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues.
Skropeta D; Schwörer R; Haag T; Schmidt RR
Glycoconj J; 2004; 21(5):205-19. PubMed ID: 15486453
[TBL] [Abstract][Full Text] [Related]
9. CMP substitutions preferentially inhibit polysialic acid synthesis.
Miyazaki T; Angata K; Seeberger PH; Hindsgaul O; Fukuda M
Glycobiology; 2008 Feb; 18(2):187-94. PubMed ID: 18077550
[TBL] [Abstract][Full Text] [Related]
10. Discrimination between activity of (alpha 2-3)-sialyltransferase and (alpha 2-6)-sialyltransferase in human platelets using p-nitrophenyl-beta-D-galactoside as acceptor.
Bauvois B; Cacan R; Fournet B; Caen J; Montreuil J; Verbert A
Eur J Biochem; 1982 Jan; 121(3):567-72. PubMed ID: 7035171
[TBL] [Abstract][Full Text] [Related]
11. Assay of sialyltransferase activity by reversed-phase ion-pair high-performance liquid chromatography.
Spiegel LB; Hadjimichael J; Rossomando EF
J Chromatogr; 1992 Jan; 573(1):23-7. PubMed ID: 1564102
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of CMP-9''-modified-sialic acids as donor substrate analogues for mammalian and bacterial sialyltransferases.
Kajihara Y; Kamitani T; Sato R; Kamei N; Miyazaki T; Okamoto R; Sakakibara T; Tsuji T; Yamamoto T
Carbohydr Res; 2007 Sep; 342(12-13):1680-8. PubMed ID: 17572399
[TBL] [Abstract][Full Text] [Related]
13. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
14. In vitro synthesis of colominic acid by membrane-bound sialyltransferase of Escherichia coli K-235. Kinetic properties of this enzyme and inhibition by CMP and other cytidine nucleotides.
Ortiz AI; Reglero A; Rodríguez-Aparicio LB; Luengo JM
Eur J Biochem; 1989 Jan; 178(3):741-9. PubMed ID: 2643517
[TBL] [Abstract][Full Text] [Related]
15. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
Li W; Niu Y; Xiong DC; Cao X; Ye XS
J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
[TBL] [Abstract][Full Text] [Related]
16. Evidence for an O-glycan sialylation system in brain. Characterization of a beta-galactoside alpha 2,3-sialyltransferase from rat brain regulating the expression of an alpha-N-acetylgalactosaminide alpha 2,6-sialyltransferase activity.
Baubichon-Cortay H; Broquet P; George P; Louisot P
Eur J Biochem; 1989 Jun; 182(2):257-65. PubMed ID: 2472271
[TBL] [Abstract][Full Text] [Related]
17. Unliganded and CMP-Neu5Ac bound structures of human α-2,6-sialyltransferase ST6Gal I at high resolution.
Harrus D; Harduin-Lepers A; Glumoff T
J Struct Biol; 2020 Nov; 212(2):107628. PubMed ID: 32971290
[TBL] [Abstract][Full Text] [Related]
18. Systematic syntheses and inhibitory activities of bisubstrate-type inhibitors of sialyltransferases.
Hinou H; Sun XL; Ito Y
J Org Chem; 2003 Jul; 68(14):5602-13. PubMed ID: 12839452
[TBL] [Abstract][Full Text] [Related]
19. Determination of the specificities of rat liver Gal(beta 1-4)GlcNAc alpha 2,6-sialyltransferase and Gal(beta 1-3/4)GlcNAc alpha 2,3-sialyltransferase using synthetic modified acceptors.
Wlasichuk KB; Kashem MA; Nikrad PV; Bird P; Jiang C; Venot AP
J Biol Chem; 1993 Jul; 268(19):13971-7. PubMed ID: 8314763
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.
Izumi M; Wada K; Yuasa H; Hashimoto H
J Org Chem; 2005 Oct; 70(22):8817-24. PubMed ID: 16238314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
